US Stock MarketDetailed Quotes

Impact BioMedical (IBO)

Watchlist
  • 0.6526
  • -0.0024-0.37%
Close Apr 24 16:00 ET
  • 0.6300
  • -0.0226-3.46%
Post 20:01 ET
70.36MMarket Cap-1.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Impact BioMedical (IBO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
32K
7K
18K
7K
0
0
0
0
0
0
Operating revenue
--32K
--7K
--18K
--7K
--0
--0
--0
--0
--0
--0
Cost of revenue
424K
422K
1K
11K
0
0
0
0
Gross profit
-392K
-415K
17K
-4K
0
0
0
0
Operating expense
14.16%3.88M
-15.09%743K
-14.37%965K
83.55%1.15M
31.00%1.01M
-15.67%3.4M
-23.18%875K
4.55%1.13M
-37.90%626K
-3.99%771K
Selling and administrative expenses
8.04%1.98M
-53.47%275K
-28.23%516K
215.89%676K
66.89%509K
65.67%1.83M
361.72%591K
65.29%719K
-53.28%214K
-9.50%305K
-Selling and marketing expense
-96.21%24K
-98.63%2K
-99.57%2K
-94.44%1K
137.50%19K
873.85%633K
595.24%146K
2,611.76%461K
80.00%18K
-52.94%8K
-General and administrative expense
63.21%1.95M
-38.65%273K
99.22%514K
244.39%675K
64.98%490K
15.11%1.2M
315.89%445K
-38.28%258K
-56.25%196K
-7.19%297K
Research and development costs
22.30%340K
201.85%110K
-36.59%52K
-38.02%75K
-43.72%103K
-83.50%278K
-117.14%-108K
-77.03%82K
-54.51%121K
2.23%183K
Depreciation amortization depletion
2.32%1.15M
2.51%286K
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
-Depreciation and amortization
2.32%1.15M
2.51%286K
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
0.00%280K
Other operating expenses
143.86%417K
-36.28%72K
142.22%109K
816.67%110K
3,733.33%115K
43.70%171K
11.88%113K
650.00%45K
200.00%12K
-57.14%3K
Operating profit
-25.70%-4.27M
-32.34%-1.16M
15.88%-948K
-84.19%-1.15M
-31.00%-1.01M
15.67%-3.4M
23.18%-875K
-4.55%-1.13M
37.90%-626K
3.99%-771K
Net non-operating interest income expense
25.86%-780K
101.12%3K
14.24%-259K
0.39%-257K
-18.06%-268K
-144.08%-1.05M
-118.85%-267K
-205.05%-302K
-128.32%-258K
-131.63%-227K
Non-operating interest income
0.00%13K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
0.00%13K
0.00%3K
0.00%3K
0.00%3K
0.00%3K
Non-operating interest expense
-25.54%793K
--0
-14.10%262K
-0.38%260K
17.83%271K
139.86%1.07M
116.00%270K
199.02%305K
125.00%261K
127.72%230K
Other net income (expense)
53.67%-9.4M
114.68%3.81M
-104.73%-268K
-12.94M
-39,115.38%-20.29M
-25.96M
5.67M
Gain on sale of security
----
----
-104.73%-268K
----
----
----
----
--5.67M
----
----
Special income (charges)
99.95%-12K
----
----
----
----
---25.36M
----
----
----
----
-Less:Impairment of capital assets
--0
----
----
----
----
--25.36M
----
----
----
----
-Gain on sale of property,plant,equipment
---12K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-285.24%-9.39M
----
----
---12.94M
----
9,646.15%5.07M
----
----
----
----
Income before tax
41.59%-14.45M
109.80%2.66M
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-461.31%-24.74M
-2,049.09%-27.1M
460.32%4.24M
21.14%-884K
-17.55%-998K
Income tax
-7,918.18%-2.58M
-7,918.18%-2.58M
0
0
0
33K
33K
0
0
0
Net income
52.08%-11.87M
119.29%5.24M
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.32%4.24M
21.14%-884K
-17.55%-998K
Net income continuous Operations
52.08%-11.87M
119.29%5.24M
-134.78%-1.48M
-1,523.53%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.32%4.24M
21.14%-884K
-17.55%-998K
Minority interest income
48.39%-32K
60.00%-10K
16.67%-5K
-220.00%-6K
69.44%-11K
12.68%-62K
3.85%-25K
60.00%-6K
126.32%5K
81.25%-36K
Net income attributable to the parent company
52.09%-11.84M
119.35%5.25M
-134.61%-1.47M
-1,513.72%-14.35M
-31.70%-1.27M
-469.83%-24.71M
-2,094.98%-27.11M
465.49%4.25M
19.33%-889K
-46.42%-962K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
52.09%-11.84M
119.35%5.25M
-134.61%-1.47M
-1,513.72%-14.35M
-31.70%-1.27M
-469.83%-24.71M
-2,094.98%-27.11M
465.49%4.25M
19.33%-889K
-46.42%-962K
Basic earnings per share
83.48%-0.38
101.98%0.0501
-132.43%-0.12
-1,426.13%-1.18
-31.47%-0.11
-3,185.71%-2.3
-2,255.39%-2.53
466.10%0.37
19.33%-0.0773
-46.45%-0.0837
Diluted earnings per share
83.48%-0.38
101.98%0.0501
-300.00%-0.12
-1,426.13%-1.18
-31.47%-0.11
-3,185.71%-2.3
-2,255.39%-2.53
159.37%0.06
19.33%-0.0773
-46.45%-0.0837
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 32K7K18K7K000000
Operating revenue --32K--7K--18K--7K--0--0--0--0--0--0
Cost of revenue 424K422K1K11K0000
Gross profit -392K-415K17K-4K0000
Operating expense 14.16%3.88M-15.09%743K-14.37%965K83.55%1.15M31.00%1.01M-15.67%3.4M-23.18%875K4.55%1.13M-37.90%626K-3.99%771K
Selling and administrative expenses 8.04%1.98M-53.47%275K-28.23%516K215.89%676K66.89%509K65.67%1.83M361.72%591K65.29%719K-53.28%214K-9.50%305K
-Selling and marketing expense -96.21%24K-98.63%2K-99.57%2K-94.44%1K137.50%19K873.85%633K595.24%146K2,611.76%461K80.00%18K-52.94%8K
-General and administrative expense 63.21%1.95M-38.65%273K99.22%514K244.39%675K64.98%490K15.11%1.2M315.89%445K-38.28%258K-56.25%196K-7.19%297K
Research and development costs 22.30%340K201.85%110K-36.59%52K-38.02%75K-43.72%103K-83.50%278K-117.14%-108K-77.03%82K-54.51%121K2.23%183K
Depreciation amortization depletion 2.32%1.15M2.51%286K2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K
-Depreciation and amortization 2.32%1.15M2.51%286K2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K0.00%280K
Other operating expenses 143.86%417K-36.28%72K142.22%109K816.67%110K3,733.33%115K43.70%171K11.88%113K650.00%45K200.00%12K-57.14%3K
Operating profit -25.70%-4.27M-32.34%-1.16M15.88%-948K-84.19%-1.15M-31.00%-1.01M15.67%-3.4M23.18%-875K-4.55%-1.13M37.90%-626K3.99%-771K
Net non-operating interest income expense 25.86%-780K101.12%3K14.24%-259K0.39%-257K-18.06%-268K-144.08%-1.05M-118.85%-267K-205.05%-302K-128.32%-258K-131.63%-227K
Non-operating interest income 0.00%13K0.00%3K0.00%3K0.00%3K0.00%3K0.00%13K0.00%3K0.00%3K0.00%3K0.00%3K
Non-operating interest expense -25.54%793K--0-14.10%262K-0.38%260K17.83%271K139.86%1.07M116.00%270K199.02%305K125.00%261K127.72%230K
Other net income (expense) 53.67%-9.4M114.68%3.81M-104.73%-268K-12.94M-39,115.38%-20.29M-25.96M5.67M
Gain on sale of security ---------104.73%-268K------------------5.67M--------
Special income (charges) 99.95%-12K-------------------25.36M----------------
-Less:Impairment of capital assets --0------------------25.36M----------------
-Gain on sale of property,plant,equipment ---12K------------------------------------
Other non- operating income (expenses) -285.24%-9.39M-----------12.94M----9,646.15%5.07M----------------
Income before tax 41.59%-14.45M109.80%2.66M-134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-461.31%-24.74M-2,049.09%-27.1M460.32%4.24M21.14%-884K-17.55%-998K
Income tax -7,918.18%-2.58M-7,918.18%-2.58M00033K33K000
Net income 52.08%-11.87M119.29%5.24M-134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.32%4.24M21.14%-884K-17.55%-998K
Net income continuous Operations 52.08%-11.87M119.29%5.24M-134.78%-1.48M-1,523.53%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.32%4.24M21.14%-884K-17.55%-998K
Minority interest income 48.39%-32K60.00%-10K16.67%-5K-220.00%-6K69.44%-11K12.68%-62K3.85%-25K60.00%-6K126.32%5K81.25%-36K
Net income attributable to the parent company 52.09%-11.84M119.35%5.25M-134.61%-1.47M-1,513.72%-14.35M-31.70%-1.27M-469.83%-24.71M-2,094.98%-27.11M465.49%4.25M19.33%-889K-46.42%-962K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 52.09%-11.84M119.35%5.25M-134.61%-1.47M-1,513.72%-14.35M-31.70%-1.27M-469.83%-24.71M-2,094.98%-27.11M465.49%4.25M19.33%-889K-46.42%-962K
Basic earnings per share 83.48%-0.38101.98%0.0501-132.43%-0.12-1,426.13%-1.18-31.47%-0.11-3,185.71%-2.3-2,255.39%-2.53466.10%0.3719.33%-0.0773-46.45%-0.0837
Diluted earnings per share 83.48%-0.38101.98%0.0501-300.00%-0.12-1,426.13%-1.18-31.47%-0.11-3,185.71%-2.3-2,255.39%-2.53159.37%0.0619.33%-0.0773-46.45%-0.0837
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -